Expert Financial Analysis and Reporting

Recent Reports

• Antares Pharma: The Xyosted Launch Continues to Look Good (ATRS, Buy, $3.37) (0)

Recent Blogs

• Part 9 of Illegal Naked Shorting Series:  The Risk/ Reward of Shorting Versus Buying Stocks is Extremely Unfavorable (0)
• Cryoport: I View the Just Completed Equity Offering as a Major Positive (CYRX, Buy, $18.00) (0)
• Part 8: Illegal Naked Shorting Series: Who or What is Cede and What Role Does Cede Play in the Trading of Stocks? (0)
• Antares Pharma: Detailed Sales and Earnings Model Through 2021 (ATRS, $2.85, Buy) (0)
• Part 7: Illegal Naked Shorting: DTCC Continuous Net Settlement and Stock Borrowing Programs Have Loopholes That Facilitate Illegal Naked Shorting (0)
• Antares Pharma: The Xyosted Launch Looks Like it will Meet or Beat Wall Street Expectations for 2019 (ATRS, Buy, $2.90) (0)
• Part 6 Illegal Naked Shorting: The SEC’s Regulation SHO is Intended to Prevent Illegal Naked Shorting, But is Ineffective (0)
• Northwest Biotherapeutics: Takeaways from Marnix Bosch’s Presentation at ASCO (NWBO, Buy, $0.27) (0)
• Part 5 in Series on Illegal Naked Shorting’s Role in Stock Manipulation: Traditional Shorting Compared to Naked Shorting (Both Legal and Illegal) (0)
• Cryoport: Details of My Model for Sales for 2018 to 2024 (CYRX, Buy, $16.88) (0)
• Ondexxya Receives Conditional EU Approval as Expected (PTLA, Buy, $36.44) (0)

Social Feeds

• • $ CYRX Cryoport: The Bristol-Myers Acquisition of Celgene is a Validation of my Investment Thesis for Cryoport… https://t.co/TQ4KFbritg, Jan 09
  • $PTLA Portola: Tidbits from Presentation at JP Morgan Healthcare Conference (PTLA, Buy, $21.96) https://t.co/76AuWyEbFH, Jan 09
  • $BMY Negative Market Reaction to Celgene Acquisition is a Buying Opportunity https://t.co/0aybnueJbx, Jan 04
  • $nwbo $46 million non-dilutive financing provides major boost to investment outlook. See my report. https://t.co/pidvWRoYUR, Dec 17
  • $cyrx Cryoport raises a $25 million warchest for acquisiitons https://t.co/OyAt5ZlY87, Dec 17